TheraVet: Commercial Launch of BIOCERA-VET® in Germany

GOSSELIES, Belgium & WALLONIA, Belgium, January 17, 2024--Regulatory News: TheraVet (ISIN: BE0974387194 – ticker: ALVET) (Paris:ALVET), a pioneering company in the management of osteoarticular diseases in pets, announces today the commercial launch of its BIOCERA-VET® products in Germany.

Related Keywords

Brussels ,Bruxelles Capitale ,Belgium ,Paris ,France General ,France ,Leipzig ,Sachsen ,Germany ,Wallonia ,Waals Gewest ,Gosselies ,Newcap Belgique ,Martin Nicolas Fossiez ,Deutsche Heimtiermarkt ,Arthur Rouill ,Animal Health ,Wallonia Export Investment Agency ,Financial Communications ,Attendance To Leipzig Veterinary Congress ,Leipzig Veterinary Congress ,Regulatory News ,Wallonia Export ,Investment Agency ,The Company ,Anine Osteosarcoma ,Bone Diseases ,Business Wire ,